Industry committee  Thank you. For Médecins Sans Frontières' viewpoint, we have a certain amount of money to spend on the drugs. We want to treat as many people as possible with quality drugs, so we're going to keep going the generic route. We haven't had enough success in having enough affordable

Industry committee  We've been urging that for years, frankly, so--

Industry committee  I would agree with you about the galaxy of problems and the real politics of why these countries are not asking for drugs. I won't go down the corruption route, because MSF is concerned too. We're spending Canadian and international and Swiss money, and we have donations from a

Industry committee  To your first question, I don't feel an appropriate place to comment about CIDA, and working with...I mean, we have a WTO commitment, a WTO decision that Canada was part of. We have legislation that's not working. We put a lot of effort into seeing if it would work, and then havi

Industry committee  I mentioned that when Canada announced that it would be the first to implement the legislation, immediately we spoke with our colleagues. As I said, we are in many countries. We decided that we would try to use it, for a couple reasons: first, to see if it's workable, and second.

Industry committee  Thank you for your question. This legislation had every champion in the government when it was passed. It had all-party agreement. So it started out with every government person championing it. At MSF we are able to work in war zones and in difficult countries because of our m

Industry committee  We have been discussing this with one country, and they will not do TRIPS notification. We've also brought this, and MSF's potential interest as an organization procuring a lot of drugs, to the attention of other developing countries, and to our knowledge, they have not done any

Industry committee  Thank you, Mr. Chair, honourable members, for giving Médecins Sans Frontières the opportunity to appear here today. I thank you for allowing us to appear before your committee today. I am here representing MSF as a humanitarian. I'm not an intellectual property lawyer or a pate